Expert Rev Anticancer Ther
-
Publication Venue For
- Emerging predictive biomarkers in the management of bone and soft tissue sarcomas.. 23:495-502. 2023
- Efficacy, safety and toxicity management of adjuvant abemaciclib in early stage HR+/HER2- high-risk breast cancer.. 22:805-814. 2022
- Treatment of cervical cancer: overcoming challenges in access to brachytherapy.. 22:353-359. 2022
- The role of immunotherapy in fusion-driven lung cancer.. 21:461-464. 2021
- Individualizing systemic therapy for advanced soft tissue sarcomas based on tumor histology and biology.. 20:5-8. 2020
- New advances in focal therapy for early stage prostate cancer.. 17:737-743. 2017
- Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?. 16:625-632. 2016
- Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls.. 16:303-311. 2016
- Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.. 16:391-401. 2016
- Optimal therapy for desmoid tumors: current options and challenges for the future.. 15:1443-1458. 2015
- The evolving role of radiotherapy in treatment of oligometastatic NSCLC.. 15:1459-1471. 2015
- Brain metastases in breast cancer.. 14:173-183. 2014
- Current and emerging surveillance strategies to expand the window of opportunity for curative treatment after surgery in colorectal cancer.. 13:439-450. 2013
- Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy.. 13:451-459. 2013
- Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML.. 12:1289-1297. 2012
- Reirradiation for recurrent head and neck cancer.. 12:1177-1189. 2012
- Primary systemic therapy in HER2-amplified breast cancer: a clinical review.. 12:1005-1013. 2012
- Radiotherapy following radical prostatectomy.. 12:973-979. 2012
- Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.. 10:1825-1836. 2010
- Optimizing regional infusion treatment strategies for melanoma of the extremities.. 9:1599-1609. 2009
- Extreme hypofractionation for prostate cancer.. 9:61-65. 2009
- Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.. 8:717-732. 2008
- Emerging role of intensity-modulated radiation therapy in anorectal cancer.. 8:585-593. 2008
- Open radical retropubic prostatectomy 2007: the true minimally invasive surgery for localized prostate cancer?. 7:1309-1317. 2007
- Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.. 7:675-687. 2007
- Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.. 6:1105-1110. 2006
- Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.. 6:679-695. 2006
- Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors.. 4:981-989. 2004